125 related articles for article (PubMed ID: 2424197)
1. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations].
Kiseleva IA; Kandiurina VG; Timofeeva GV
Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197
[TBL] [Abstract][Full Text] [Related]
2. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations].
Chekan LV; Min'ovich FL; Kutimova LR; Edvabnaia LS; Stanislavskiĭ ES
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):85-9. PubMed ID: 6170196
[TBL] [Abstract][Full Text] [Related]
3. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection].
Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793
[TBL] [Abstract][Full Text] [Related]
4. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
Podgornaia LG; Dziuban NF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
[TBL] [Abstract][Full Text] [Related]
5. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
Fisher MW
J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
[TBL] [Abstract][Full Text] [Related]
6. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa].
Nazarchuk LV
Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin].
Ianishevskaia MN; Kuz'mina NS; Kutimova LR; Lents MN; Minakova LV
Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):100-3. PubMed ID: 6412489
[TBL] [Abstract][Full Text] [Related]
8. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
Collins MS; Ladehoff DK; Mehton NS; Noonan JS
FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
10. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
Horn MP; Zuercher AW; Imboden MA; Rudolf MP; Lazar H; Wu H; Hoiby N; Fas SC; Lang AB
Antimicrob Agents Chemother; 2010 Jun; 54(6):2338-44. PubMed ID: 20308370
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
Zaĭdner IG; Stanislavskiĭ ES; Gladus MA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
Moriyama K; Wiener-Kronish JP; Sawa T
Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
[TBL] [Abstract][Full Text] [Related]
13. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
14. [Protective action of various antibody preparations in experimental bacterial sepsis].
Trautmann M; Brückner O; Hofstaetter T; Seiler FR; Hahn H
Beitr Infusionther Klin Ernahr; 1982; 9():155-65. PubMed ID: 6816213
[No Abstract] [Full Text] [Related]
15. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic properties of slime produced by Pseudomonas aeruginosa.
Maresz-Babczyszyn J; Sokalska M
Arch Immunol Ther Exp (Warsz); 1979; 27(4):585-9. PubMed ID: 117786
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
Iushkova NA; Stanislavskiĭ ES; Landsman NM
Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
19. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
Pennington JE; Pier GB; Sadoff JC; Small GJ
Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
